AccScience Publishing / ARNM / Online First / DOI: 10.36922/arnm.4005
SHORT COMMUNICATION

Simulated study relating dose-volume histogram metrics to three-dimensional gamma analysis results

Larisse Neumann Bonatto1 Alexandre Colello Bruno1 Oswaldo Baffa2* Juliana Fernandes Pavoni1,2
Show Less
1 Department of Radiotherapy, Ribeirão Preto Medical School Hospital and Clinics, University of São Paulo, Av. Bandeirantes, Monte Alegre, Ribeirão Preto, São Paulo, Brazil
2 Department of Physics, Faculty of Philosophy, Sciences and Letters at Ribeirão Preto, University of São Paulo, Av. Bandeirantes, Monte Alegre, Ribeirão Preto, São Paulo, Brazil
Submitted: 21 June 2024 | Accepted: 11 October 2024 | Published: 13 November 2024
© 2024 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Abstract

This study aims to investigate the relationship between the three-dimensional gamma index (3DGI) results and its clinical significance, proposing a correlation between changes in dose values in the dose-volume histogram (DVH) of the evaluated structures and 3DGI percentages of approval. In this study, we created 30 plans by including 1 mm displacement errors in the lateral, vertical, and longitudinal axes of each table, and compared them to a simulated, error-free treatment plan for prostate cancer. The plans were made in a commercial treatment planning system, using 6MV Varian 120-leaf multileaf collimators (MLC) linear accelerators and intensity modulated radiation therapy sliding window technique. We used a calculation algorithm-based MATLAB programming to evaluate the 3DGI analysis of fluence maps. The acceptance criteria were 3%/2 mm, 10% dose threshold, and 95% gamma passing rate. We compared 3DGI results with differences in structures DVH. DVH metrics versus 3DGI analysis showed a correlation between the percentage of point’s approval and planning target volume (PTV) coverage, presenting a degree of agreement of 0.85%, 0.96%, and 0.94% in the longitudinal, lateral, and vertical axes, respectively. In summary, it was possible to establish a linear relationship between the percentage of points approved in the 3DGI analysis and the PTV dose. A similar behavior was also observed in bladder and rectum DVH, but for these structures, the relationship was not the same in the three displaced axes.

Keywords
3D gamma index
Radiotherapy
Fluence maps
Intensity-modulated radiation therapy
Quality assurance
Funding
This work was financially supported by the Brazilian Agencies: CNPq (Grants 407471/2016-, 305827/2023-5 and 304921/2021-1); São Paulo Research Foundation (FAPESP) (Grants 2021/02254-6, and CEPID-NEUROMAT 2013/07699-0), and Sistema Único de Saúde (SUS).
Conflict of interest
The authors declare that they have no competing interests.
References
  1. Cancer Today. Available from: https://gco.iarc.who.int/ today [Last accessed on 2024 Jun 20].

 

  1. Howlader N, Noone A, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2018. National Cancer Institute; 2021. Available from: https://seer.cancer.gov/csr/1975_2018/ index.html [Last accessed on 2024 Jun 20]

 

  1. Schaeffer EM, Srinivas S, Adra N, et al. Prostate cancer, version 4. NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2023;21(10):1067-1096. doi: 10.6004/jnccn.2023.0050

 

  1. Tilki D, Van den Bergh RCN, Briers E, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Part II-2024 update: Treatment of relapsing and metastatic prostate cancer. Eur Urol. 2024;86:164-182. doi: 10.1016/j.eururo.2024.04.010

 

  1. Cornford P, Van den Bergh RC, Briers E, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer-2024 Update. Part I: Screening, diagnosis, and local treatment with curative Intentt. Eur Urol. 2024;86(2):148-163. doi: 10.1016/j.eururo.2024.03.027

 

  1. Miften M, Olch A, Mihailidis D, et al. Tolerance limits and methodologies for IMRT measurement-based verification QA: Recommendations of AAPM Task Group No. 218. Med Phys. 2018;45(4):e53-e83. doi: 10.1002/mp.12810

 

  1. Low DA, Harms WB, Mutic S, Purdy JA. A technique for the quantitative evaluation of dose distributions. Med Phys. 1998;25(5):656-661. doi: 10.1118/1.598248

 

  1. Low DA, Moran JM, Dempsey JF, Dong L, Oldham M. Dosimetry tools and techniques for IMRT. Med Phys. 2011;38(3):1313-1338. doi: 10.1118/1.3514120

 

  1. Tamborra P, Martinucci E, Massafra R, et al. The 3D isodose structure-based method for clinical dose distributions comparison in pretreatment patient-QA. Med Phys. 2019;46(2):426-436. doi: 10.1002/mp.13297

 

  1. Nelms BE, Zhen H, Tomé WA. Per-beam, planar IMRT QA passing rates do not predict clinically relevant patient dose errors. Med Phys. 2011;38(2):1037-1044. doi: 10.1118/1.3544657

 

  1. Stasi M, Bresciani S, Miranti A, Maggio A, Sapino V, Gabriele P. Pretreatment patient-specific IMRT quality assurance: A correlation study between gamma index and patient clinical dose volume histogram. Med Phys. 2012;39(12):7626-7634. doi: 10.1118/1.4767763

 

  1. Ezzell GA, Burmeister JW, Dogan N, et al. IMRT commissioning: Multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119. Med Phys. 2009;36(11):5359-5373. doi: 10.1118/1.3238104
Share
Back to top
Advances in Radiotherapy & Nuclear Medicine, Electronic ISSN: 2972-4392 Published by AccScience Publishing